Complications · Patients with insufficient bone below the maxillary sinus requiring dental implants
1 finding from 1 review
Raghoebar 2005: 1 complication in the non-PRP arm, OR 0.27 (0.01 to 8.46), P = 0.46; Torres 2009 (PRP only = 3, no-PRP only = 2), OR 1.49 (0.15 to 15.07), P = 1.00. No statistically significant difference.
2 studies · 62 participants
GRADE not reported
Complications · Patients with 3 to 6 mm of residual bone height at the sinus floor
One-stage crestal-approach sinus lift with autogenous bone and 8 mm… showed no clear difference in complications compared with lateral-window sinus lift with 50% autogenous bone/50% Bio-Oss and…; GRADE not reported.
1 finding from 1 review
Complications (at treated sites) · Patients with missing teeth and an atrophic posterior maxilla, with residual bone height between 4 and 9 mm below the maxillary sinus
Maxillary sinus lift (augmentation) with long implants may leads to higher complications (at treated sites) compared with short implants (5 to 8.5 mm) without sinus augmentation (low certainty).
1 finding from 1 review
Implant failure · Patients with 3 to 6 mm of residual bone height at the sinus floor
One-stage crestal-approach sinus lift with autogenous bone and 8 mm… showed no clear difference in implant failure compared with lateral-window sinus lift with 50% autogenous bone/50% Bio-Oss and…; GRADE not reported.
1 finding from 1 review
Time to complete healing · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
Sucralfate suspension (topical) showed no clear difference in healing time compared with placebo suspension; GRADE not reported.
1 finding from 1 review
Number of episodes · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
Sucralfate suspension (topical) showed no clear difference in number of episodes compared with placebo suspension; GRADE not reported.
1 finding from 1 review
Augmentation procedure failure · Patients with missing teeth and an atrophic posterior maxilla, with residual bone height between 4 and 9 mm below the maxillary sinus
1 finding from 1 review
Pain (0-3 scale) · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
Sucralfate suspension (topical) showed no clear difference in pain (0-3 scale) compared with placebo suspension; GRADE not reported.
1 finding from 1 review
Implant failure · Patients with missing teeth and an atrophic posterior maxilla, with residual bone height between 4 and 9 mm below the maxillary sinus
Maxillary sinus lift (augmentation) with long implants showed no clear difference in implant failure compared with short implants (5 to 8.5 mm) without sinus augmentation (moderate certainty).
1 finding from 1 review
Total number of oral ulcers · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
Interferon-alpha (topical; hydrogel or lozenges) showed no clear difference in total number of oral ulcers compared with placebo; GRADE not reported.
1 finding from 1 review
Partial graft loss · Patients with 3 to 6 mm of residual bone height at the sinus floor
One-stage crestal-approach sinus lift with autogenous bone and 8 mm… showed no clear difference in partial graft loss compared with lateral-window sinus lift with 50% autogenous bone/50% Bio-Oss and…; GRADE not reported.
1 finding from 1 review
Implant failure · Patients with 2 to 7 mm of residual alveolar bone height in the edentulous maxillary sinus floor
One-stage lateral sinus lift with monocortical autogenous bone… showed no clear difference in implant failure compared with two-stage lateral sinus lift with autogenous particulate bone (iliac…; GRADE not reported.
1 finding from 1 review
Safety of the intervention (adverse effects) · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
1 finding from 1 review
Patient preference · Patients undergoing crestal maxillary sinus lift
1 finding from 1 review
Five months after loading, 13 of 15 patients preferred the side treated with the Cosci (rotary) technique; binomial test P = 0.007 (significant). Basis for the review's low-quality-evidence statement that patients may…
1 study · 15 participants
GRADE not reported
Prosthesis failure · Patients undergoing lateral-window maxillary sinus lift
1 finding from 1 review
Rickert 2013 (split-mouth, N = 36): no prosthesis failures in either group.
1 study · 36 participants
GRADE not reported
Implant failure · Patients undergoing one-stage crestal maxillary sinus lift without bone grafts (baseline residual bone height about 6.5 mm)
Hand mallet (osteotomes) showed no clear difference in implant failure compared with electric mallet; GRADE not reported.
1 finding from 1 review
Global aphthae count and pain score · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
1 finding from 1 review
Matsuda 2003 (rebamipide 300 mg daily vs placebo, 35 patients; high risk of reporting bias; concomitant treatments): authors stated that rebamipide improved the global evaluation aphthae count and global evaluation…
1 study · 35 participants
GRADE not reported
Prosthesis failure · Patients with 3 to 6 mm of residual bone height at the sinus floor
One-stage crestal-approach sinus lift with autogenous bone and 8 mm… showed no clear difference in prosthesis failure compared with lateral-window sinus lift with 50% autogenous bone/50% Bio-Oss and…; GRADE not reported.
1 finding from 1 review
Prosthesis failure · Patients with an atrophic maxillary sinus requiring augmentation (1 to 5 mm residual bone height)
Sinus lift with bone graft (granular Bio-Oss) showed no clear difference in prosthesis failure compared with sinus lift without bone graft (Inion resorbable rigid barrier…; GRADE not reported.
1 finding from 1 review
Total ulcer burden · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
1 finding from 1 review
Interventions for managing oral ulcers in Behçet's disease 2014 · Cochrane All outcomesInterferon-alpha dose comparison
Kilic 2009 (interferon-alpha 1000 IU vs 2000 IU lozenges, 84 patients): the data presented did not allow analysis; authors reported no statistically significant difference in total ulcer burden between the two doses.
1 study · 84 participants
GRADE not reported